Adar1 Capital Management, LLC Pure Tech Health PLC Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
A detailed history of Adar1 Capital Management, LLC transactions in Pure Tech Health PLC stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 700 shares of PRTC stock, worth $14,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700Holding current value
$14,560% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTC
# of Institutions
6Shares Held
20.1KCall Options Held
0Put Options Held
0-
Pentwater Capital Management LP Naples, FL16.2KShares$336,8140.01% of portfolio
-
Morgan Stanley New York, NY2.83KShares$58,8010.0% of portfolio
-
Ubs Group Ag351Shares$7,3000.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY73Shares$1,5180.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $580M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...